Bioavailability Differences
Bioavailability Differences is a toxicokinetic parameter that denotes the variation in the rate and extent to which a xenobiotic reaches systemic circulation across species due to physiological, metabolic, or anatomical disparities.
33
Publications
1.1K
Citations
117
Authors
55
Institutions
Publications per year
2017–2026
9
33
Gail A. Harkey, Peter F. Landrum, Stephen J. Klaine · Environmental Toxicology and Chemistry · 1994 · 126 citations
Chronopharmacology of amitriptyline
Shigeyuki Nakano, Leo E. Hollister · Clinical Pharmacology & Therapeutics · 1983 · 58 citations
Hyesook Kim, Michael B. Zemel · Journal of Food Science · 1986 · 53 citations
1–5 of 33
117
2
h-index
2
h-index
2
h-index
NOAA Great Lakes Environmental Research Laboratory, United States
2 publications · 137 citations
2
h-index
United States Department of Veterans Affairs, United States
2 publications · 78 citations
2
h-index
1–5 of 117
55

The University of Queensland
Brisbane, Australia
2 h-index
9 publications
225 citations
Ehime University
Matsuyama, Japan
2 h-index
4 publications
156 citations
Stanford University
Stanford, United States
2 h-index
4 publications
156 citations

Kapiolani Medical Center for Women and Children
Honolulu, United States
1 h-index
1 publications
18 citations

China Pharmaceutical University
Nanjing, China
1 h-index
1 publications
10 citations
Department of Food Technology and Quality Control
Kathmandu, Nepal
1 h-index
2 publications
46 citations
Clemson University
Clemson, United States
1 h-index
2 publications
252 citations
Universidad Complutense de Madrid
Madrid, Spain
1 h-index
3 publications
90 citations
1–8 of 55
Repository · 3 publications · 75 citations
3
h-index
2 publications · 71 citations
2
h-index
2 publications · 137 citations
2
h-index
CPT · 2 publications · 98 citations
2
h-index
BJN · 2 publications · 65 citations
2
h-index
1–5